Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus

Arthritis Care and Research

Volumn 69, Issue 1, 2017, Pages 124-132

  George, Angela ^a   Wong Pak, Andrew ^b   Peschken, Christine A ^c   Silverman, Earl ^d   Pineau, Christian ^e   Smith, C Douglas ^f   Arbillaga, Hector ^g   Zummer, Michel ^h   Bernatsky, Sasha ^e   Hudson, Marie ⁱ   Hitchon, Carol ^c   Fortin, Paul R ^j   Nevskaya, Tatiana ^k   Pope, Janet E ^k  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

^j UNIVERSITÉ LAVAL   (Canada)

^k ST JOSEPH S HEALTH CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; END STAGE RENAL DISEASE; FEMALE; HIGH SCHOOL; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; ORGAN INJURY; PREVALENCE; RISK FACTOR; SOCIAL STATUS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS AMERICAN COLLEGE OF RHEUMATOLOGY DAMAGE INDEX; WORK DISABILITY; AGED; CANADA; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SOCIOECONOMICS;

ADULT; AGED; CANADA; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 85006035812     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22922     Document Type: Article

References (46)

1. Sule S, Petri M. Socioeconomic status in systemic lupus erythematosus. Lupus 2006;15:720–3.
2. Marmot MG, Smith GD, Stansfeld S, Patel C, North F, Head J, et al. Health inequalities among British civil servants: the Whitehall study. Lancet 1991;337:1387–93.
3. Chen E, Miller GE. Socioeconomic status and health: mediating and moderating factors. Ann Rev Clin Psychol 2013;9:723–49.
4. Calvillo-King L, Arnold D, Eubank KJ, Lo M, Yunyongying P, Stieglitz H, et al. Impact of social factors on risk of readmission or mortality in pneumonia and heart failure: systemic review. J Gen Intern Med 2013;28:269–82.
5. Marmot M, Allen J, Bell R, Bloomer E, Goldblatt P. WHO European review of social determinants of health and the health divide. Lancet 2012;380:1011–29.
6. Cooper GS, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. Arthritis Rheum 2007;57:993–9.
7. Trupin L, Tonner MC, Yazdany J, Julian LJ, Criswell LA, Katz PP, et al. The role of neighbourhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol 2008;35:1782–8.
8. Ward M. Education level and mortality in systemic lupus erythematosus: evidence of under ascertainment of deaths due to SLE in ethnic minorities with low education levels. Arthritis Rheum 2004;51:616–24.
9. Lau CS, Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol 2009;5:400–4.
10. Alarcón GS, Bastian HM, Beasley TM, Roseman JM, Tan FK, Fessler BJ, et al. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: contributions of admixture and socioeconomic status to renal involvement. Lupus 2006;15:26–31.
11. Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology (Oxford) 2009;48:281–4.
12. Demas KL, Costenbader KH. Disparities in lupus care and outcomes. Curr Opin Rheumatol 2009;21:102–9.
13. Jolly M, Mikolaitis RA, Shakoor N, Fogg LF, Block JA. Education, zip code-based annualized household income, and health outcomes in patients with systemic lupus erythematosus. J Rheumatol 2010;37:1150–7.
14. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socioeconomic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999;38:1130–7.
15. Esdaile JM, Sampalis JS, Lacaille D, Danoff D. The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus. Arthritis Rheum 1988;31:423–7.
16. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
17. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Roberts WN, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995;38:267–73.
18. Bae SC, Koh HK, Chang DK, Kim MH, Park JK, Kim SY. Reliability and validity of Systemic Lupus Activity Measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 2001;10:405–9.
19. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, for the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630–40.
20. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematous. Arthritis Rheum 1996;39:363–9.
21. Alarcón GS, McGwin G Jr, Sanchez ML, Bastian HM, Fessler BJ, Friedman AW, et al. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum 2004;51:73–7.
22. Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797–806.
23. Alarcón GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups: VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. Arthritis Rheum 2001;45:191–202.
24. Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, et al. The G LAD EL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among “Hispanics.” Medicine (Baltimore) 2004;83:1–17.
25. Calvo-Alen J, Reveille JD, Rodriguez-Valverde V, McGwin G Jr, Baethge BA, Friedman A, et al. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 2003;12:377–85.
26. Bertoli AM, Vilá LM, Reveille JD, Alarcón GS, and the LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus. Ann Rheum Dis 2008;67:500–4.
27. Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J, et al. Prognosis in proliferative lupus nephritis: the role of socioeconomic status and race/ethnicity. Nephrol Dial Transplant 2003;18:2039–46.
28. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006;85:147–56.
29. Mendoza-Pinto C, Méndez-Martínez S, Soto-Santillán P, Galindo Herrera J, Pérez-Contreras I, Macías-Díaz S, et al. Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women. Lupus 2015;24:1227–32.
30. Maynard JW, Fang H, Petri M. Low socioeconomic status is associated with cardiovascular risk factors and outcomes in systemic lupus erythematosus. J Rheumatol 2012;39:777–83.
31. Katsicas MM, Russo R. Relationship between lower socioeconomic level and outcome measures in juvenile systemic lupus erythematosus [abstract]. Ann Rheum Dis 2014;Suppl 2:1100.
32. Kulczycka L, Sysa-Jedrzejowska A, Zalewska-Janowska A, Miniszewska J, Robak E. Quality of life and socioeconomic factors in Polish patients with systemic lupus erythematosus. J Eur Acad Dermatol Venereol 2008;22:1218–26.
33. Abdul-Sattar AB, Abou El Magd S. Association of perceived neighborhood characteristics, socioeconomic status and rural residency with health outcomes in Egyptian patients with systemic lupus erythematosus: one center study. Int J Rheum Dis 2014. DOI: 10.1111/1756-185X.12331.
34. Bultink IE, Turkstra F, Dijkmans BA, Voskuyl AE. High prevalence of unemployment in patients with systemic lupus erythematosus: association with organ damage and health-related quality of life. J Rheumatol 2008;35:1053–7.
35. Law G, Pope J, Lalani S, Silverman E, Cooper G, Fortin P, et al, and the CaNIOS Investigators. Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus patients: patient and physician perceptions. Clin Med Arthritis Musculoskelet Disord 2009;2:1–8.
36. Lee SS, Singh S, Magder LS, Petri M. Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus. Lupus 2008;17:114–23.
37. Galobardes B, Lynch JW, Davey Smith G. Childhood socioeconomic circumstances and cause-specific mortality in adulthood: systematic review and interpretation. Epidemiol Rev 2004;26:7–21.
38. Castrejón I, Tani C, Jolly M, Huang A, Mosca M. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol 2014;5 Suppl 85:S85–95.
39. Romero-Diaz J, Isenberg D, Ramsey-Goldman R. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Arthritis Care Res (Hoboken) 2011;Suppl 11:S37–46.
40. Yazdany J, Gillis JZ, Trupin L, Katz P, Panopalis P, Criswell LA, et al. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum 2007;57:593–600.
41. Walsh SJ, DeChello LM. Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus 2001;10:637–46.
42. Peschken CA, Esdaile JM. Systemic lupus erythematosus in North American Indians: a population based study. J Rheumatol 2000;27:1884–91.
43. Rivest C, Lew RA, Welsing PM, Sangha O, Wright EA, Roberts WN, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000;27:680–4.
44. Hopkinson ND, Jenkinson C, Muir KR, Doherty M, Powell RJ. Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis 2000;59:116–9.
45. Adler M, Chambers S, Edwards C, Neild G, Isenberg D. An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford) 2006;45:1144–7.
46. Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups: XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002;11:152–60.